Dimensional Fund Advisors LP boosted its holdings in shares of OR Royalties Inc. (NYSE:OR – Free Report) by 26.5% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 677,822 shares of the basic materials company’s stock after purchasing an additional 141,904 shares during the period. Dimensional Fund Advisors LP’s holdings in OR Royalties were worth $25,759,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds also recently added to or reduced their stakes in the business. FIL Ltd acquired a new stake in OR Royalties during the 4th quarter worth about $29,000. Assetmark Inc. purchased a new stake in shares of OR Royalties in the fourth quarter worth about $36,000. Banque Cantonale Vaudoise purchased a new stake in shares of OR Royalties in the first quarter worth about $37,000. Allworth Financial LP boosted its stake in shares of OR Royalties by 20.0% in the fourth quarter. Allworth Financial LP now owns 2,305 shares of the basic materials company’s stock worth $82,000 after buying an additional 384 shares during the last quarter. Finally, Sequoia Financial Advisors LLC acquired a new stake in OR Royalties during the first quarter worth about $204,000. 68.52% of the stock is owned by hedge funds and other institutional investors.
OR Royalties Trading Up 5.1%
OR opened at $32.32 on Thursday. The firm has a market capitalization of $6.05 billion, a PE ratio of 24.12 and a beta of 0.75. The firm’s 50-day moving average price is $31.86 and its 200 day moving average price is $37.35. OR Royalties Inc. has a twelve month low of $27.54 and a twelve month high of $48.06.
Analysts Set New Price Targets
OR has been the subject of several recent research reports. Jefferies Financial Group reduced their price target on OR Royalties from $40.00 to $34.00 and set a “hold” rating for the company in a research report on Monday, July 6th. Wall Street Zen cut OR Royalties from a “buy” rating to a “hold” rating in a research report on Saturday, June 6th. Royal Bank Of Canada reduced their target price on OR Royalties from $50.00 to $45.00 and set an “outperform” rating for the company in a research note on Thursday, July 9th. Scotiabank decreased their target price on OR Royalties from $51.00 to $42.00 and set a “sector perform” rating on the stock in a research report on Tuesday, July 14th. Finally, Weiss Ratings cut shares of OR Royalties from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Friday, July 24th. One analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $40.50.
Check Out Our Latest Report on OR Royalties
OR Royalties Profile
OR Royalties PLC (NYSE: OR) is a closed-ended investment company that specializes in acquiring and managing royalty interests in life science and pharmaceutical products. The company provides capital to biotechnology, specialty pharmaceutical and medical device companies in exchange for a share of future sales revenues. By focusing on royalties secured against marketed products, OR Royalties aims to deliver income and growth potential while minimizing the development and commercialization risks typically associated with direct equity stakes.
The company’s core activities include sourcing royalty transactions, structuring bespoke financing solutions and actively monitoring a diversified portfolio of assets.
Featured Articles
- Five stocks we like better than OR Royalties
- SpaceX: Love the Company, But the Stock Is a Harder Call
- Ulta’s Growth Is Real, But So Are the Risks
- BWX Technologies Is Turning the AI Power Problem Into a Nuclear Growth Story
- Meta’s Earnings Drop Shows Wall Street Wants More Than Ad Growth
Want to see what other hedge funds are holding OR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for OR Royalties Inc. (NYSE:OR – Free Report).
Receive News & Ratings for OR Royalties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OR Royalties and related companies with MarketBeat.com's FREE daily email newsletter.
